- Novo Nordisk drops lawsuit against Hims & Hers after reaching an agreement on drug sales.
- Hims & Hers will now offer Novo Nordisk's branded medicines like Ozempic and Wegovy.
- Hims & Hers agrees to halt the advertising of compounded GLP-1 drugs, prioritizing FDA-approved medications.
- The deal aims to maintain affordability and limit compounded drugs to rare, FDA-compliant cases.
Family Business, Family Rules
Let me tell you something about family. It ain't always blood. Sometimes, it's about respect, loyalty, and knowing when to back down. Word on the street is Novo Nordisk and Hims & Hers were throwing punches over some weight loss drugs. Seems like they've decided to settle things the right way, no more courtroom drama. They're putting family – or, in this case, patients – first.
The Price of Loyalty… and Semaglutide
Hims is gonna start selling Novo's stuff, Ozempic and Wegovy, same price as everyone else. That's how it should be. No gouging the people who need it. And get this, they're pulling the plug on advertising those copycat GLP-1 drugs. It's about doing things the right way, even if it means taking a hit. Speaking of doing things right, have you read about Cato Networks' AI-Fueled Ascent Hits $350 Million Milestone? Different world, same principle: build something solid, something that lasts, and always look out for your own. They are committed to security and innovation.
FDA's Blessing: The Green Light We Needed
The big dogs at the FDA are happy too. Says Hims is gonna stop pushing those unapproved drugs and stick to the real deal. They're even gonna keep things affordable, which is huge. Sometimes, you gotta listen to the people in charge, even if you don't always see eye to eye. It's about respect. And family respects the rules. I live my life a quarter mile at a time, but I always watch out for my family.
The Shortage: A Bump in the Road
So, Hims was selling these copycat drugs 'cause of a shortage. But Novo fixed that problem. Now, they're cranking out the real stuff. Hims tried to say their versions were "personalized," but let's be real, sometimes you just gotta stick to the original recipe. Like my Corona – always the same, always good.
Second Chances and Broken Promises
This ain't the first time Novo and Hims have tried to play nice. They had a deal before, but it went south. Accusations flew, things got ugly. But this time, it sounds like they're serious about making it work. Hims is changing its game, focusing on the real deal. Never turn your back on family, even when they hurt you.
What's Next on the Horizon
The weight loss drug game is changing fast. Hims wants to team up with anyone who's got the goods, new therapies, big drug companies, the whole shebang. And Eli Lilly's got a new pill coming out soon, too. It's a race, plain and simple. But family always comes first. And in this race, the patients are family.
Comments
- No comments yet. Become a member to post your comments.